MCID: PLX001
MIFTS: 32

Plexiform Schwannoma malady

Categories: Cancer diseases, Neuronal diseases

Aliases & Classifications for Plexiform Schwannoma

About this section

Aliases & Descriptions for Plexiform Schwannoma:

Name: Plexiform Schwannoma 10 12 65
Plexiform Neurilemmoma 10
 
Plexiform Neurinoma 10

Classifications:



External Ids:

Disease Ontology10 DOID:3206
NCIt42 C6969
UMLS65 C1370659

Summaries for Plexiform Schwannoma

About this section
MalaCards based summary: Plexiform Schwannoma, also known as plexiform neurilemmoma, is related to transitional meningioma and melanotic neurilemmoma. An important gene associated with Plexiform Schwannoma is NF2 (Neurofibromin 2 (Merlin)), and among its related pathways is Mesenchymal Stem Cell Differentiation Pathways and Lineage-specific Markers. Affiliated tissues include bone, cerebellum and lung, and related mouse phenotypes are respiratory system and digestive/alimentary.

Related Diseases for Plexiform Schwannoma

About this section

Diseases related to Plexiform Schwannoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 159)
idRelated DiseaseScoreTop Affiliating Genes
1transitional meningioma10.5DSP, NF2
2melanotic neurilemmoma10.4NF1, NF2
3adult fibrosarcoma10.4NF1, NF2
4cellular neurofibroma10.4NF1, NF2
5chest wall lymphoma10.4NF1, NF2
6pituitary stalk meningioma10.4MIB1, NF2
7nerve root neoplasm10.4DSP, KIT
8skull base meningioma10.4MIB1, NF2
9epilepsy, familial focal, with variable foci10.4NF1, NF2
10skin benign neoplasm10.3KIT, NGFR
11gangliocytoma10.3ENO2, KIT
12sublingual gland adenoid cystic carcinoma10.3KIT, NGFR
13large cell carcinoma with rhabdoid phenotype10.3ENO2, NF1
14bartholin's gland small cell carcinoma10.3ENO2, KIT
15follicular infundibulum tumor10.3B3GAT1, NF1
16childhood cerebellar neoplasm10.3GFAP, NF2
17myositis ossificans10.3B3GAT1, CDSN
18anaplastic ganglioglioma10.3GFAP, NF2
19seminal vesicle adenocarcinoma10.3ENO2, KIT
20pilomyxoid astrocytoma10.3GFAP, NF2
21diffuse pulmonary fibrosis10.3ENO2, KIT
22eye disease10.3GFAP, NF2
23hepatitis10.3
24tuberculosis10.3
25heroin dependence10.3
26myxopapillary ependymoma10.2GFAP, NF2
27penis non-invasive verrucous carcinoma10.2ENO2, MIB1
28papillary ependymoma10.2GFAP, NF2
29complement component 3 deficiency10.2GFAP, NF1
30decubitus ulcer10.2KIT, NF1, NF2
31alveoli adenoma10.2GFAP, MIB1
32spina bifida occulta10.2ENO2, KIT
33adult malignant schwannoma10.2GFAP, MIB1
34pulmonary plasma cell granuloma10.2B3GAT1, ENO2
35posterior foramen magnum meningioma10.2B3GAT1, ENO2
36head and neck carcinoma10.2GFAP, KIT
37colon small cell carcinoma10.2GFAP, MIB1
38meninges hemangiopericytoma10.2ENO2, MIB1
39neurofibroma of gallbladder10.2CD34, DSP
40plexiform schwannoma10.2CD34, NF2
41head injury10.1
42spinal cord oligodendroglioma10.1GFAP, MIB1
43preretinal fibrosis10.1NF1, NF2
44fibrous meningioma10.1CD34, NF2
45corneal neovascularization10.1ENO2, NF1, NF2
46pyelonephritis10.1ENO2, NF1, NF2
47anus leiomyosarcoma10.1CD34, KIT
48syphilis10.1ENO2, GFAP
49submandibular gland cancer10.1CD34, KIT
50ovary rhabdomyosarcoma10.1CD34, KIT

Graphical network of the top 20 diseases related to Plexiform Schwannoma:



Diseases related to plexiform schwannoma

Symptoms for Plexiform Schwannoma

About this section

Drugs & Therapeutics for Plexiform Schwannoma

About this section

Drugs for Plexiform Schwannoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 11)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Doxorubicinapproved, investigationalPhase 2, Phase 3158223214-92-831703
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
111266-55-8
14-Hydroxydaunomycin
14-Hydroxydaunorubicine
14-hydroxydaunomycin
14-hydroxydaunorubicine
23214-92-8
23257-17-2
24385-08-8
25311-50-6
25316-40-9
25316-40-9 (hydrochloride)
29042-30-6
AC1L1M5T
AC1Q29OJ
ADM
ADR
Adriablastin
Adriacin (hydrochloride salt)
Adriamycin
Adriamycin PFS
Adriamycin PFS (hydrochloride salt)
Adriamycin RDF
Adriamycin RDF (hydrochloride salt)
Adriamycin Semiquinone
Adriamycin semiquinone
Adriblas tina
Adriblastin
Adriblastina
Adriblastina (TN)
Adriblastina (hydrochloride salt)
Aerosolized Doxorubicin
BPBio1_000502
BRD-K92093830-003-04-3
BSPBio_000456
BSPBio_001031
C01661
C27H29NO11
CCRIS 739
CHEBI:28748
CHEMBL179
CID31703
Caelyx
Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74
Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120
D03899
DB00997
DM2
DOX-SL
Doxil
Doxo
Doxorubicin
Doxorubicin (USAN/INN)
Doxorubicin HCl
 
Doxorubicin Hydrochloride
Doxorubicin [USAN:INN:BAN]
Doxorubicin citrate
Doxorubicin hydrochloride (hydrochloride salt)
Doxorubicin-P4/D10
Doxorubicin-P4/D10 conjugate
Doxorubicin-hLL1
Doxorubicin-hLL1 conjugate
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicine
Doxorubicine [INN-French]
Doxorubicinum
Doxorubicinum [INN-Latin]
EINECS 245-495-6
FI 106
Farmablastina (hydrochloride salt)
HMS2089H06
HSDB 3070
Hydroxydaunomycin hydrochlor ide (hydrochloride salt)
Hydroxydaunomycin hydrochloride (hydrochloride salt)
Hydroxydaunorubicin
Hydroxydaunorubicin hydrochloride (hydrochloride salt)
JT9100000
LMPK13050001
LS-1029
LS-165655
MLS000759533
Myocet
NCI-C01514
NChemBio.2007.10-comp13
NDC 38242-874
NIOSH/JT9100000
NSC 123127
Prestwick0_000438
Prestwick1_000438
Prestwick2_000438
Prestwick3_000438
Probes1_000151
Probes2_000129
RDF Rubex
Resmycin
Rubex
Rubex (hydrochloride salt)
SMP1_000106
SPBio_002395
TLC D-99
ThermoDox
Triferric doxorubicin
UNII-80168379AG
adiblastine (hydrochloride salt)
adr iablatina (hydrochloride salt)
adriablastine (hydrochloride salt)
adriablatina (hydrochloride salt)
adriblatina (hydrochloride salt)
doxorubicin
nchembio809-comp5
2
IfosfamideapprovedPhase 2, Phase 33713778-73-23690
Synonyms:
(+-)-Ifosfamid
(+-)-Ifosphamide
(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
(D,L)-Ifosfamide
(R,S)-Ifosphamide
(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd
2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI)
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
3,} 2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
36341-88-5
3778-73-2
84711-20-6
A 4942
AB00513932
AC-2113
AC1L1GHW
ASTA Z 4942
Ambap3778-73-2
Asta Z 4942
BPBio1_000865
BRN 0611835
BSPBio_000785
C07047
CAS-3778-73-2
CCRIS 352
CHEBI:5864
CHEMBL1024
CID3690
Cyfos
D00343
D007069
DB01181
EINECS 223-237-3
HMS1570H07
HMS2090M12
HMS2093N07
HSDB 7023
Holoxan
Holoxan 1000
I-Phosphamide
I06-0494
IFEX (TN)
Ifex
Ifosfamid
Ifosfamida
Ifosfamida [INN-Spanish]
Ifosfamide
 
Ifosfamide (JAN/USP/INN)
Ifosfamide Sterile
Ifosfamide [USAN:INN:BAN:JAN]
Ifosfamidum
Ifosfamidum [INN-Latin]
Ifosphamide
Ifsofamide
Iphosphamid
Iphosphamid(e)
Iphosphamide
Iso Endoxan
Iso-Endoxan
Isoendoxan
Isofosfamide
Isophosphamide
Isosfamide
LS-102
LS-99799
MJF 9325
MJF-9325
MLS002154021
Mitoxana
Mitoxana, Ifex, Ifosfamide
MolPort-003-666-704
N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German]
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide
N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine
NCGC00016639-01
NCGC00179435-01
NCI-C01638
NCI60_000233
NPFAPI-04
NSC 109,724
NSC 109724
NSC-109,724
NSC-109724
NSC109,724
NSC109724
Naxamide
Prestwick0_000833
Prestwick1_000833
Prestwick2_000833
Prestwick3_000833
S1302_Selleck
SMR001233348
SPBio_002706
STL058690
UNII-UM20QQM95Y
WLN: T6NPOTJ AM2G BO B2G
Z 4942
Z-4942
Z4942
ifosfamide
isosfamide
{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,
3
MechlorethamineapprovedPhase 2, Phase 330951-75-24033
Synonyms:
.Beta.,.beta.'-Dichlorodiethyl-N-methylamine
1, 5-Dichloro-3-methyl-3-azapentane hydrochloride
126-85-2 (N-oxide)
2,2'-Dichloro-N-me
2,2'-Dichloro-N-methyldiethylamine
2,2'-Dichlorodiethyl-methylamine
2,2'-dichloro-N-methyldiethylamine
2-Chloro-N-(2-chloroethyl)-N-methylethanamine
302-70-5 (N-oxide, hydrochloride)
51-75-2
55-86-7 (HYDROCHLORIDE)
AC1L1H9H
Antimit
BRN 0605323
BSPBio_001947
Bis(2-chloroethyl)methylamine
Bis(beta-chloroethyl) methylamine
Bis(beta-chloroethyl)methylamine
C07115
C5H11Cl2N
CCRIS 447
CHEBI:28925
CHEMBL427
CID4033
Carolysine
Caryolysin
Caryolysine
Chloramine (the nitrogen mustard)
Chlorethazine
Chlormethine
Chlormethine (INN)
Chlormethine [INN:BAN]
Chlormethinum [INN-Latin]
Cloramin
Clormetina
Clormetina [INN-Spanish]
D07671
DB00888
Di(2-chloroethyl)methylamine
Dichlor amine
Dichloren
DivK1c_000759
EINECS 200-120-5
ENT-25294
Embechine
Embichin
HMS1920J15
HMS2091B04
HMS502F21
HN-2
HN2
HSDB 5083
I14-8708
IBS-L0033631
IDI1_000759
KBio1_000759
KBio2_001369
KBio2_003937
KBio2_006505
KBio3_001447
KBioGR_001448
 
KBioSS_001369
LS-7559
MBA
Me chloroethamine
Mebichloramine
Mechlorethamine
Mechlorethamine hydrochloride
Mechlorethanamine
Mechloroethamine
Mecloretamina
Mecloretamina [Italian]
Methylbis(2-chloroethyl)amine
Methylbis(beta-chloroethyl)amine
Methyldi(2-chloroethyl)amine
Mitoxine (*Hydrochloride*)
MolPort-001-785-592
Mustargen
Mustine
Mustine note
Mutagen
N,N-Bis(2-chloroethyl)-N-methylamine
N,N-Bis(2-chloroethyl)methylamine
N,N-Di(chloroethyl)methylamine
N-Lost
N-Methyl lost
N-Methyl-2,2'-dichlorodiethylamine
N-Methyl-bis(2-chloroethyl)amine
N-Methyl-bis(beta-chloroethyl)amine
N-Methyl-bis-chloraethylamin
N-Methyl-bis-chloraethylamin [German]
N-Methyl-lost
N-Methyl-lost [German]
N-methyl-bis(2-chloroethyl)amine
NCGC00091835-02
NCGC00091835-03
NCGC00091835-04
NCGC00091835-05
NCI60_041682
NINDS_000759
NSC762
Nitol (*Hydrochloride*)
Nitrogen mustard
Nitrogen mustard (HN-2)
Nitrogranulogen
SPBio_000496
SPECTRUM1500375
Spectrum2_000448
Spectrum3_000484
Spectrum4_000924
Spectrum5_001702
Spectrum_000889
Stickstofflost (*Hydrochloride*)
Stickstofflost (ebewe)
T 1024
T-1024
TL 146
UNII-50D9XSG0VR
Valchlor
beta,Beta'-dichlorodiethyl-N-methylamine
beta,beta'-Dichlorodiethyl-N-methylamine
mechlorethamine
thyldiethylamine
β,β'-dichlorodiethyl-N-methylamine
4
Cyclophosphamideapproved, investigationalPhase 2, Phase 3264350-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
DB00531
 
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
5
DoxilApproved June 1999Phase 2, Phase 3158231703
Synonyms:
Dox-SL
Doxil
 
Evacet
LipoDox
Pegylated Liposomal Doxorubicin Hydrochloride
liposomal doxorubicin
6Anti-Bacterial AgentsPhase 2, Phase 39140
7Topoisomerase InhibitorsPhase 2, Phase 34081
8Isophosphamide mustardPhase 2, Phase 3371
9Antibiotics, AntitubercularPhase 2, Phase 35971
10Antineoplastic Agents, AlkylatingPhase 2, Phase 33406
11Alkylating AgentsPhase 2, Phase 33582

Interventional clinical trials:

idNameStatusNCT IDPhase
1Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by SurgeryRecruitingNCT02180867Phase 2, Phase 3
2Natural History Study of Patients With Neurofibromatosis Type IRecruitingNCT00924196
3Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1RecruitingNCT02211768Phase 0
4Whole Body Magnetic Resonance Imaging With Diffusion Weighted Imaging : Potential Role in NeurofibromatosisRecruitingNCT01777451

Search NIH Clinical Center for Plexiform Schwannoma

Genetic Tests for Plexiform Schwannoma

About this section

Anatomical Context for Plexiform Schwannoma

About this section

MalaCards organs/tissues related to Plexiform Schwannoma:

33
Bone, Cerebellum, Lung, Salivary gland

Animal Models for Plexiform Schwannoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Plexiform Schwannoma:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053888.7ENO2, KIT, NF1, NF2, NGFR
2MP:00053818.1DSP, GFAP, KIT, MIB1, NF1, NGFR
3MP:00107717.8CD34, DSP, KIT, MIB1, NF1, NF2
4MP:00053867.5B3GAT1, ENO2, GFAP, KIT, NF1, NF2
5MP:00053827.5DSP, ENO2, KIT, MIB1, NF1, NF2
6MP:00053787.2DSP, ENO2, GFAP, KIT, MIB1, NF1
7MP:00036316.7B3GAT1, DSP, ENO2, GFAP, KIT, MIB1
8MP:00053846.6CD34, DSP, ENO2, GFAP, KIT, MIB1

Publications for Plexiform Schwannoma

About this section

Articles related to Plexiform Schwannoma:

(show top 50)    (show all 59)
idTitleAuthorsYear
1
Phototherapeutic keratectomy (PTK) for treatment of recurrent corneal erosion: Correlation between etiology and prognosis - prospective longitudinal study. (25900814)
2015
2
Genetics of familial melanoma: 20 years after CDKN2A. (25431349)
2015
3
Management setting of obstructive sleep apnea. (23821095)
2013
4
Genetic variants in epidermal growth factor receptor pathway genes and risk of esophageal squamous cell carcinoma and gastric cancer in a Chinese population. (23874846)
2013
5
An Outbreak of a Nosocomial NDM-1-Producing Klebsiella pneumoniae ST147 at a Teaching Hospital in Mainland China. (24199986)
2013
6
IL-1 signaling in atherosclerosis: sibling rivalry. (24048132)
2013
7
Preventive Pharmacotherapy in Migraine. (24261479)
2013
8
Van der woude syndrome associated with hypodontia: a rare clinical entity. (23326687)
2012
9
Baker's Cyst on F-18 FDG PET/CT in a Patient with Ocular Melanoma. (23486655)
2012
10
Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population. (21186997)
2011
11
Cerebellar Purkinje cell loss is not pathognomonic of essential tremor. (20817536)
2011
12
Genetic variations at the lipoprotein lipase gene influence plasma lipid concentrations and interact with plasma n-6 polyunsaturated fatty acids to modulate lipid metabolism. (21840003)
2011
13
Episodes of Fall Asleep During Day Time in an Elder Woman with Vascular Dementia: Impact on Cerebral Ischeamic Tolerance and Utility of ECG Holter Monitoring. (21160915)
2010
14
Induction of metallothionein in mouse cerebellum and cerebrum with low-dose thimerosal injection. (19357975)
2010
15
Prevalence of radiographic lumbar spondylosis and its association with low back pain in elderly subjects of population-based cohorts: the ROAD study. (18718988)
2009
16
Central serous chorioretinopathy after sequential argon-neodymium: YAG laser iridotomies. (19320308)
2009
17
Cooperative regulation of the interferon regulatory factor-1 tumor suppressor protein by core components of the molecular chaperone machinery. (19502235)
2009
18
Leptin protection of salivary gland acinar cells against ethanol cytotoxicity involves Src kinase-mediated parallel activation of prostaglandin and constitutive nitric oxide synthase pathways. (18340408)
2008
19
The Nup358-RanGAP complex is required for efficient importin alpha/beta-dependent nuclear import. (18305100)
2008
20
In vitro antagonism of recombinant ligand-gated ion-channel receptors by stereospecific enantiomers of bupivacaine. (16418020)
2006
21
mRNA expression of RASSF1A in esophageal squamous cell carcinoma and clinical significance thereof]. (16854302)
2006
22
Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia--Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR). (17184550)
2006
23
Role of tissue factor in hemostasis and thrombosis. (16466951)
2006
24
Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individuals. (16141277)
2005
25
Caspase-9 can antagonize p53-induced apoptosis by generating a p76(Rb) truncated form of Rb. (15735701)
2005
26
Management of diabetes mellitus and insulin resistance in patients with cardiovascular disease. (12957327)
2003
27
The mechanism of p21-activated kinase 2 autoactivation. (12907671)
2003
28
Role of cyclin G-associated kinase in uncoating clathrin-coated vesicles from non-neuronal cells. (10625686)
2000
29
L-aspartase: new tricks from an old enzyme. (10800598)
2000
30
Oxidative stress disrupts glucocorticoid hormone-dependent transcription of the amiloride-sensitive epithelial sodium channel alpha-subunit in lung epithelial cells through ERK-dependent and thioredoxin-sensitive pathways. (10722699)
2000
31
Separating the primary autonomic failure syndromes, multiple system atrophy, and pure autonomic failure from Parkinson's disease. (10410741)
1999
32
Is selection responsible for the low level of variation in the last intron of the ZFY locus? (10555294)
1999
33
Elevation of serum thrombopoietin precedes thrombocytosis in Kawasaki disease. (9657430)
1998
34
A cdc15-like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2-triggered adhesion. (9857189)
1998
35
Purification and molecular cloning of SH2- and SH3-containing inositol polyphosphate-5-phosphatase, which is involved in the signaling pathway of granulocyte-macrophage colony-stimulating factor, erythropoietin, and Bcr-Abl. (9108392)
1997
36
Cloning and characterization of a human STE20-like protein kinase with unusual cofactor requirements. (9353338)
1997
37
Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis. (9150467)
1997
38
Expression of stromelysin 1 in human astrocytoma cell lines. (8943093)
1996
39
Sleep bruxism: validity of clinical research diagnostic criteria in a controlled polysomnographic study. (8655758)
1996
40
Low bioavailable testosterone levels predict future height loss in postmenopausal women. (7610937)
1995
41
Keratinocyte growth factor accelerates corneal epithelial wound healing in vivo. (7601632)
1995
42
Nanoleakage: leakage within the hybrid layer. (8700762)
1995
43
Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. (7475605)
1995
44
Reduplication after right middle cerebral artery infarction. (8292326)
1993
45
Detection of Shigellae and enteroinvasive Escherichia coli by amplification of the invasion plasmid antigen H DNA sequence in patients with dysentery. (8421181)
1993
46
Revised DNA sequence of exon 1 and 5' flanking region of the human tissue factor pathway inhibitor gene. (8327992)
1993
47
Human plasma lecithin:cholesterol acyltransferase. Preparation and use of immobilized p-aminophenylarsenoxide as a catalytic site-directed covalent ligand in enzyme purification. (1770111)
1991
48
Scurvy amongst central Australian Aboriginal children. (5434887)
1970
49
50

Variations for Plexiform Schwannoma

About this section

Expression for genes affiliated with Plexiform Schwannoma

About this section
Search GEO for disease gene expression data for Plexiform Schwannoma.

Pathways for genes affiliated with Plexiform Schwannoma

About this section

Pathways related to Plexiform Schwannoma according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
18.9CD34, KIT, NGFR

GO Terms for genes affiliated with Plexiform Schwannoma

About this section

Cellular components related to Plexiform Schwannoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1myelin sheathGO:00432099.3ENO2, GFAP

Biological processes related to Plexiform Schwannoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1negative regulation of cell-matrix adhesionGO:000195310.1NF1, NF2
2visual learningGO:00085429.8KIT, NF1
3single organismal cell-cell adhesionGO:00163378.7CD34, CDSN, DSP

Sources for Plexiform Schwannoma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet